Diego Cadavid

Officer, Fulcrum Therapeutics (United States).

Companies

X4 Pharmaceuticals, IncChief Medical Officer Dec 14, 2020 to Mar 1, 2022¹
Fulcrum Therapeutics (United States)Officer Jul 17, 2019 to Jul 2, 2020²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

X4 Pharmaceuticals, Inc XFOR104,107 shares³$267.0K at $2.56Mar 1, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 1, 2022Granted 97,000 shares of X4 Pharmaceuticals, Inc³
Feb 11, 2022Sold 928 shares of X4 Pharmaceuticals, Inc⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARX4 Pharmaceuticals, Inc, Chief Medical Officer
2
SEC EDGARFulcrum Therapeutics (United States), Officer
3
SEC EDGARX4 Pharmaceuticals, Inc shares after the filing of Mar 1, 2022
4
SEC EDGARForm 4 filed Feb 14, 2022